Caleres Inc CAL
We take great care to ensure that the data presented and summarized in this overview for CALERES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CAL
View all-
Black Rock Inc. New York, NY5.41MShares$55.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$25 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.75MShares$18.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.51MShares$15.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$13.3 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY1.16MShares$12 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.07MShares$11.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY927KShares$9.56 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA922KShares$9.51 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA872KShares$8.99 Million0.57% of portfolio
Latest Institutional Activity in CAL
Top Purchases
Top Sells
About CAL
Caleres, Inc. engages in the retail and wholesale of footwear in the United States, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products to women, men, and children. Its retail shoe stores provide brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Converse, Crocs, Puma, Birkenstock, New Balance, Asics, New Balance, Under Armour, Bearpaw, Timberland, Sperry, and Dr. Martens, as well as company-owned and licensed brands, such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Zodiac, Circus by Sam Edelman, Franco Sarto, and Ryka. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, allenedmonds.com, drschollsshoes.com, lifestride.com, francosarto.com, ryka.com, bzees.com, and zodiacshoes.com, as well as Vince.com, blowfishshoes.com, and veronicabeard.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalogs. Further, the company wholesales men's apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear under the Bzees brand; other footwear under Zodiac brand; and women's footwear collection under Veronica Beard brand, as well as Via Spiga brand. It operates approximately 980 retail stores. The company was formerly known as Brown Shoe Company, Inc. Caleres, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.
Insider Transactions at CAL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2025
|
Ward M Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,316
+2.23%
|
$23,160
$10.79 P/Share
|
|
Nov 01
2025
|
Molly Langenstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,316
+10.77%
|
$23,160
$10.79 P/Share
|
|
Sep 12
2025
|
Jack Calandra SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,671
-6.86%
|
$70,065
$15.22 P/Share
|
|
Sep 08
2025
|
Brian P Costello Div President, Famous Footwear |
BUY
Grant, award, or other acquisition
|
Direct |
12,962
+34.5%
|
-
|
|
Sep 08
2025
|
Kathleen K Welter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,443
+50.0%
|
-
|
|
Aug 02
2025
|
Molly Langenstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,898
+10.12%
|
$24,674
$13.17 P/Share
|
|
Aug 02
2025
|
Ward M Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,898
+1.88%
|
$24,674
$13.17 P/Share
|
|
Jun 06
2025
|
John W Schmidt President & CEO, Caleres |
BUY
Open market or private purchase
|
Direct |
7,600
+1.65%
|
$98,800
$13.39 P/Share
|
|
Jun 05
2025
|
Wenda Harris Millard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,926
+15.78%
|
-
|
|
Jun 02
2025
|
Ward M Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,131
+11.11%
|
$157,703
$13.19 P/Share
|
|
Jun 02
2025
|
Molly Langenstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,131
+44.77%
|
$157,703
$13.19 P/Share
|
|
Jun 02
2025
|
Bruce K Thorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,131
+33.16%
|
$157,703
$13.19 P/Share
|
|
Jun 02
2025
|
Mahendra R Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,131
+23.66%
|
$157,703
$13.19 P/Share
|
|
May 22
2025
|
Diane M Sullivan Executive Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
14,739
-14.5%
|
$235,824
$16.49 P/Share
|
|
May 03
2025
|
Molly Langenstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,579
+35.76%
|
$23,685
$15.83 P/Share
|
|
Mar 27
2025
|
Lori Greeley Director |
BUY
Open market or private purchase
|
Direct |
9,000
+21.04%
|
$153,000
$17.75 P/Share
|
|
Mar 24
2025
|
John W Schmidt President & CEO, Caleres |
BUY
Grant, award, or other acquisition
|
Direct |
145,519
+24.61%
|
-
|
|
Mar 24
2025
|
Willis Hill Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,066
+21.62%
|
-
|
|
Mar 24
2025
|
Todd E Hasty SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,372
+22.94%
|
-
|
|
Mar 24
2025
|
Daniel R Freidman Chief Sourcing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,463
+18.39%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 349K shares |
|---|---|
| Exercise of conversion of derivative security | 7.93K shares |
| Open market or private purchase | 21.6K shares |
| Payment of exercise price or tax liability | 146K shares |
|---|